FIGURE 2.
Frataxin depletion determines impairments in NRF-2 expression and signaling. (A) ROS determination (graph on the left) and Complex I activity (graph on the right), assessed in WT and KIKO NSCs. Cellular ROS were evaluated by measuring DCF fluorescence, normalized for cell number, while Complex I activity was expressed as nmol/min/mg prot. qPCR (B) and Western Blot analyses (C) and relative densitometric evaluation (graph on the right) of the expression of the transcription factor Nrf2, its targets (NQO1 and HO-1) and Frataxin, in WT and KIKO NSCs. GAPDH was used for qPCR normalization, while Tubulin was used as Western Blot loading control, *p < 0.05 and ∗∗p < 0.01.